{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001549595","name":"Nurix Therapeutics, Inc.","summary":"Nurix Therapeutics is a clinical-stage biopharmaceutical company focused on discovery, development, and commercialization of targeted protein degradation medicines for cancer and inflammatory diseases. Its wholly owned pipeline includes bexobrutideg (BTK degrader), zelebrudomide (BTK/IKZF1/IKZF3 degrader), and NX-1607 (CBL-B inhibitor). Nurix also has partnered programs with Gilead, Sanofi, and Pfizer, powered by its DEL-AI discovery engine integrating machine learning and DNA-encoded library screening.","people":[],"products":[{"name":"bexobrutideg (NX-5948)","type":"platform","description":"Orally bioavailable, highly selective BTK degrader in Phase 2 for relapsed/refractory CLL/SLL and WM."},{"name":"zelebrudomide (NX-2127)","type":"platform","description":"Orally bioavailable dual degrader of BTK and transcription factors IKZF1/IKZF3 in Phase 1a/1b for B-cell malignancies."},{"name":"NX-1607","type":"platform","description":"Orally bioavailable CBL-B E3 ligase inhibitor in Phase 1a/1b for solid tumor oncology indications."},{"name":"DEL-AI Discovery Engine","type":"platform","description":"AI-integrated platform using DNA-encoded libraries and machine learning for degrader and DAC drug discovery."},{"name":"NX-0479/GS-6791","type":"platform","description":"Partnered IRAK4 degrader with Gilead, IND cleared by FDA in April 2025 for inflammatory conditions."},{"name":"NX-3911 (STAT6 degrader)","type":"platform","description":"Partnered STAT6 targeted protein degrader licensed by Sanofi in June 2025, currently in IND-enabling studies."},{"name":"Pan-mutant BRAF degrader","type":"platform","description":"Preclinical degrader targeting multiple mutant BRAF forms for solid tumors including melanoma and colorectal cancer."}],"partnerships":[{"partner_name":"Gilead Sciences, Inc.","partnership_type":"development","description":"Collaboration for TPD drug discovery including IRAK4 degrader (GS-6791/NX-0479) and multiple undisclosed programs; research term extended March 2024.","start_date":null},{"partner_name":"Sanofi S.A.","partnership_type":"development","description":"Collaboration including STAT6 degrader (NX-3911) licensed June 2025 and a second undisclosed program licensed May 2025; research term extended April 2024.","start_date":null},{"partner_name":"Pfizer Inc.","partnership_type":"development","description":"Collaboration announced September 2023 under agreement with Seagen; three preclinical milestones achieved totaling $15.0 million in milestone payments.","start_date":null}],"affiliations":[],"origin":{"leaf":"fd96fbf94b9c387c8586dbfb8645c97bebe933e2a8331cab6c4f5a73d7a65884","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"d148d838a5ffd710c111841378b23cbc87df44fea89cc5060139f9361b6a610e","parent":"69c1bedb691467d389e176b08200284ee78ac3eae0aed0c5e0259e3070a9c9e8","source":"0001549595-26-000016","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":126,"hourly_limit":500,"remaining":374,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}